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Introduction
Statins inhibit cholesterol synthesis by reducing 
3-hydroxy-3-glutaryl-coenzyme A (HMG-CoA) reduc-
tase activity. It has also been shown that statins stimu-
late formation of substantial amounts of new bone, e.g.
by increasing expression of bone morphogenetic pro-
tein-2 (BMP-2), which leads to osteoblast differentia-
tion and bone formation [1,2]. Administration of statins
may also affect heterotopic ossification [3]. BMP-2
treatment of neural crest cells increases melanogenesis
by promoting the synthesis of melanin [4]. Recently, it
has been demonstrated that BMP signaling plays an
important role in melanocytes residing at hair follicles
providing the cross-talk with the melanocortin receptor-
1 pathway [5]. A number of studies investigated the
effects of statins on melanoma cells. Specifically, lovas-
tatin induces apoptosis in A375 melanoma cells and also
enhances response to chemotherapy drugs in the B16
mouse model of melanoma [6-9].
In numerous experiments investigating pleiotropic
effects of statins, reports regarding their effect on
melanogenesis are lacking. Thus, the aim of the pres-
ent work was to examine the effects of fluvastatin, 
a frequently used statin that effectively lowers serum
cholesterol level, on melanin synthesis in melanoma
B16F10 cell line. 
Materials and methods
Cells. B16F10 melanoma cells were kindly donated by Dr Tomasz
Stok³osa from Department of Immunology, Center for Biostruc-
ture, Medical University in Warsaw, Warsaw, Poland. B16F10
mouse melanoma cells were cultured in 75 cm2 flask and grown in
DMEM+GlutaMAX medium (Gibco, NY, USA) with 10% fetal
bovine serum (Gibco, NY, USA) and 1 % antibiotic/antimicotic
solution (Gibco, NY, USA). Incubation was carried out at 37 °C
under atmosphere of air-CO2 (95:5).
Antibodies. Antibodies against: tyrosinase, β-actin and secondary
antibodies (HRP-goat anti-rabbit or HRP-bovine anti mouse) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell viability assay. All experiments were performed using cells of
the same passage. After incubating B16F10 cells overnight in 
25 cm2 flasks (5x104 cells/flask), cells were passaged to Petri dish-
es (Costar, Corning, NY, USA). When cells reached 40% of con-
fluence, the medium was changed to DMEM supplemented with
either 10% FCS alone or 10% FCS with fluvastatin at concentra-
tions: 0.1 μM; 1 μM; 10 μM. Cell viability was determined in trip-
licates, using crystal violet assay [10,11]. After incubating B16F10
cells with test substances for up to 72 hours, culture medium was
removed and the cells were stained with 0.1% crystal violet in 
10% ethanol for 5 min at 37°C and rinsed four times. Crystal 
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violet-stained adherent cells were then extracted with 95% ethanol,
and absorbance was determined at 590 nm using ELISA reader
(Tecan, Salzburg, Austria). Cell viability was also tested with UVB
irradiated/non-irradiated cells.
Irradiation procedure. The source of ultraviolet was a Cosmedico
stimulator (Cosmedico Medizintechnik, Schwenningen, Germany),
which emits energy in the UVB range, with the peak at  311 nm.
Cells were irradiated in PBS to avoid formation of medium-derived
toxic photo-products [12]. After irradiation, PBS was replaced with
fresh warm growth medium with/without 1 μM fluvastatin. Cells
were irradiated once daily (100 mJ/cm2) at 24, 48 and 72 hours of
experiment and cell viability was performed after 24 hours, follow-
ing each irradiation. To examine modulation of tyrosinase mRNA,
cells were irradiated once at 12 hours of experiment. In order to
investigate protein content, cells were irradiated twice (at 24 and 
48 hours of experiment) and the measurements were done after 
24 hours following last irradiation. Non-irradiated control cells were
maintained in PBS during the time of irradiation procedure.
Total RNA isolation. RNA was isolated with NucleoSpin®RNA II
kit (Macherey-Nagel, Neumann-Neander D-52355 Duren, Ger-
many), according to producer's protocol. Quality of isolated RNA
was tested by electrophoresis in 1% agarose denaturing gel, contain-
ing 6% formaldehyde and buffered with MOPS (Sigma, Genosys,
St. Louis MO, USA). After electrophoresis, the gel was scanned with
the digital imaging system GDS9000 using GRAB-IT. 2.0 software
(UVP, Cambridge, UK). Densitometric analysis of bands was per-
formed with GelWorks software (UVP, Cambridge, UK).
Reverse transcription. RT was carried out in 20 μl of a reaction mix
containing 1 × transcription buffer, 5.5 mM MgCl2, 0.5 mM of
deoxynucleosides (dNTP), 2.5 μM oligo dT primer, 3 U of RNase
inhibitor and 6 U of reverse transcriptase (Reverse Transcription Kit,
Promega). 1 μg of total RNA was heated at 70°C for 10 min, cooled
to 2°C and added to the reaction mix. RT was performed in Eppen-
dorf Master Cycler Gradient. Samples were incubated in 42°C for 
2 h and then heated to 94°C; cDNA was stored at -20°C. 
RealTime PCR. Real Time PCR was performed in ABI Prism
7500 (Applied Biosystems, Warrington, UK) in 96-well optical
plates. Each sample was tripled and supplied with endogenous 
control (β-actin). For tyrosinase expression, the sequence of the
forward primer was 5'- GGC CAG CTT TCA GGC AGA GGT -3'
and the sequence of the reverse primer was 5'-TGG TGC TTC ATG
GGC AAA ATC -3' (Sigma, Genosys, St. Louis MO, USA). Reac-
tions were run in 25 μl volume with Power Sybr® Green PCR
Master Mix (Applied Biosystems, Warrington, UK), appropriate
primer set and 50 ng of cDNA template. Universal thermal condi-
tions, that is 10 min at 95°C, 40 cycles of 15 s at 95°C and 1 min
at 60°C, were used. Data analysis was done with sequence detec-
tion software ver. 1.2 (Applied Biosystems, Warrington, UK).
Results and discussion 
UVB irradiation of B16F10 melanoma cell line at 100
mJ/cm2 daily did not show any important effect on cell
viability 24, 48 and 72 hours after irradiation procedure,
when compared to control non-irradiated cells (Fig. 1). 
To determine which fluvastatin concentration
shows minimal/no cytotoxic effect, melanoma cells
were treated with fluvastatin at various concentrations.
Fluvastatin at 0.1 µM and 1 µM induced relatively low
cytotoxic effect during 48 hours, but after 72 hours cell
viability was markedly reduced, thus indicating that
optimal (maximal, yet not toxic) fluvastatin concentra-
tion in medium of the melanoma cell line in further
experiments would be 1 µM and incubation time
should not exceed 48 hours (Fig. 2).
UVB irradiation increased the level of  tyrosinase
mRNA in B16F10 cells. Surprisingly, in cells treated
with 1 μM fluvastatin, the level of tyrosinase mRNA
was higher when compared to the level resulting from
UVB irradiation. Finally, simultaneous irradiation and
fluvastatin treatment of B16F10 cell line triggered
additive effect of tyrosinase mRNA increase, in com-
parison to stimulation of tyrosinase by UVB (Fig. 3).
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Fig. 1. Effects of UVB irradiation in B16F10 melanoma cell line
at 100 mJ/cm2 daily on cell viability 24, 48 and 72 hours after irra-
diation procedure vs. non-irradiated control cells.
Fig. 2. Dose- and time-dependent effects of various concentrations
of fluvastatin on cell viability in B16F10 melanoma cells. Data are
presented as the averaged values ± SE for three independent exper-
iments.
In the current study we show that UVB-induced
tyrosinase synthesis of cultured B16F10 melanoma
cells is increased by fluvastatin. Levels of tyrosinase
mRNA evaluated with use of real time PCR after UVB
irradiation of B16F10 melanoma cell line and fluvas-
tatin incubation were increased.  
Statins increase expression of bone morphogenetic
protein-2 (BMP-2) gene in cells [1] which specifically
targets tyrosinase gene expression in primary quail
neural crest cultures resulting in increased melanin
synthesis [4]. On the other hand, unlike BMP-2 effect
in quail melanocytes, BMP-4 stimulates proliferation
of melanocytes, down-regulates tyrosinase mRNA and
protein levels, decreases melanin content, decreases
tyrosinase mRNA stability [13], and purified BMP-4
reduces the number of melanocytes in cultures of avian
neural crest cells [14].
Several intracellular signaling pathways have been
reported to involve transcriptional activation of tyrosi-
nase gene. Activation of microphthalmia-associated
transcription factor (MITF), that regulates tyrosinase
gene expression, is known to be a critical event during
melanogenesis [15]. Extracellular signal-regulated
kinase (ERK) phosphorylates MITF and promotes its
degradation, thereby resulting in inhibition of tyrosi-
nase expression and melanogenesis [16]. Further
investigations are required to evaluate these proposed
signaling pathways.
Since fluvastatin is usually administered orally at
daily doses of 20 to 80 mg in patients with hypercho-
lesterolemia, and the plasma concentration typically
reaches around 1.0 μmol/L [17,18] our results seem
particularly interesting from the clinical point of view.
Melanin protects the skin against UV radiation [19].
According to the above results, fluvastatin treatment
may potentially increase melanin synthesis and skin
protection against UV irradiation.
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Fig. 3. Effects of UVB irradiation, 1 μM fluvastatin (FLUVA) and
combination of UVB irradiation/1 μM fluvastatin (UVB + FLUVA)
in B16F10 cell line on the level of tyrosinase mRNA. Relative quan-
tification of mRNA levels from triplicates was averaged ± SE.
